Improving Hepatitis C Treatment in Injection Drug Users

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Hepatitis CLiver DiseasesDrug AbuseAlcoholism
Interventions
DRUG

Pegylated Interferon and Ribavirin

Both groups with receive the same medical intervention but offered at different locations

BEHAVIORAL

Psychosocial

Assessment of the likelihood of HCV treatment initiation and completion

BEHAVIORAL

On-site (MMT Clinic) HCV evaluation and treatment

Standard HCV treatment with Pegylated Interferon and Ribavirin

BEHAVIORAL

Off-site HCV evaluation and treatment

Standard HCV treatment with Pegylated Interferon and Ribavirin

Trial Locations (2)

13210

Crouse Chemical Dependency Treatment Services, Syracuse

SUNY Upstate Medical University - Department of Gastroenterology, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT00148031 - Improving Hepatitis C Treatment in Injection Drug Users | Biotech Hunter | Biotech Hunter